These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24885017)

  • 1. Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population.
    Agborsangaya CB; Lahtinen M; Cooke T; Johnson JA
    Health Qual Life Outcomes; 2014 May; 12():74. PubMed ID: 24885017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population.
    Kangwanrattanakul K; Parmontree P
    Qual Life Res; 2020 Dec; 29(12):3407-3417. PubMed ID: 32780315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
    Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
    Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
    Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
    Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn's disease.
    Rencz F; Lakatos PL; Gulácsi L; Brodszky V; Kürti Z; Lovas S; Banai J; Herszényi L; Cserni T; Molnár T; Péntek M; Palatka K
    Qual Life Res; 2019 Jan; 28(1):141-152. PubMed ID: 30225788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study.
    Janssen MF; Pickard AS; Golicki D; Gudex C; Niewada M; Scalone L; Swinburn P; Busschbach J
    Qual Life Res; 2013 Sep; 22(7):1717-27. PubMed ID: 23184421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of the EQ-5D-3L and EQ-5D-5L.
    Thompson AJ; Turner AJ
    Pharmacoeconomics; 2020 Jun; 38(6):575-591. PubMed ID: 32180162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
    Pattanaphesaj J; Thavorncharoensap M
    Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.
    Jiang J; Hong Y; Zhang T; Yang Z; Lin T; Liang Z; Lu P; Liu L; Wang B; Xu Y; Luo N
    Qual Life Res; 2021 Jul; 30(7):2045-2060. PubMed ID: 33821418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys.
    Martí-Pastor M; Pont A; Ávila M; Garin O; Vilagut G; Forero CG; Pardo Y; Tresserras R; Medina-Bustos A; Garcia-Codina O; Cabasés J; Rajmil L; Alonso J; Ferrer M
    Popul Health Metr; 2018 Aug; 16(1):14. PubMed ID: 30115092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
    Zhu J; Yan XX; Liu CC; Wang H; Wang L; Cao SM; Liao XZ; Xi YF; Ji Y; Lei L; Xiao HF; Guan HJ; Wei WQ; Dai M; Chen W; Shi JF
    Qual Life Res; 2021 Mar; 30(3):841-854. PubMed ID: 32930993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the properties of the EQ-5D-5L and EQ-5D-3L in general population in Iran.
    Rezaei S; Woldemichael A; Ahmadi S; Mohamadi Bolbanabad A; Zahir Abdullah F; Piroozi B
    Int J Health Plann Manage; 2021 Sep; 36(5):1613-1625. PubMed ID: 34013594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the three-level and the five-level versions of the EQ-5D.
    Christiansen ASJ; Møller MLS; Kronborg C; Haugan KJ; Køber L; Højberg S; Brandes A; Graff C; Diederichsen SZ; Nielsen JB; Krieger D; Holst AG; Svendsen JH
    Eur J Health Econ; 2021 Jun; 22(4):621-628. PubMed ID: 33733344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of EQ-5D-5L in stroke.
    Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
    Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
    Verstraete J; Marthinus Z; Dix-Peek S; Scott D
    Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Psychometric Properties of the EQ-5D-3L-Y and EQ-5D-5L-Y Instruments in Spanish Children and Adolescents.
    Pérez-Sousa MÁ; Olivares PR; Ramírez-Vélez R; Gusi N
    Value Health; 2021 Dec; 24(12):1799-1806. PubMed ID: 34838278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EuroQol (EQ-5D-5L) Validity in Assessing the Quality of Life in Adults With Asthma: Cross-Sectional Study.
    Hernandez G; Garin O; Dima AL; Pont A; Martí Pastor M; Alonso J; Van Ganse E; Laforest L; de Bruin M; Mayoral K; Serra-Sutton V; Ferrer M;
    J Med Internet Res; 2019 Jan; 21(1):e10178. PubMed ID: 30672744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.